Post by California Institute for Regenerative Medicine (CIRM)

Name: Osteoarthritis is a progressive joint disease, and one of the leading causes of disability, yet trea
Uploaded: 2026-06-16T22:00:54.527Z
Channel: California Institute for Regenerative Medicine (CIRM)
Description: Osteoarthritis is a progressive joint disease, and one of the leading causes of disability, yet treatment options remain limited for many patients. Hear from Genascence Corporation's founder and CEO

14,160 followers

Osteoarthritis is a progressive joint disease, and one of the leading causes of disability, yet treatment options remain limited for many patients. Hear from Genascence Corporation's founder and CEO, Tom Chalberg, PhD, on June 25 at 10:30 AM (PT), who will share an update on GNSC-001, a potential first-in-class gene therapy for knee osteoarthritis, and the progress of the CIRM-funded DONATELLO clinical trial. GNSC-001 has received both Regenerative Medicine Advanced Therapy and Fast Track designations from the FDA, highlighting its potential as an innovative treatment approach. Watch live on the CIRM YouTube channel at youtube.com/CIRMTV

Video Content